Concerns Over Healthcare Regulations and AI Development
Experts testified before a House panel on Wednesday, indicating that rules stemming from Obamacare and the Biden administration have not only raised healthcare costs but also complicated the advancement of technology in medicine, including artificial intelligence.
Dr. Ziad Obermeyer, a distinguished health policy professor at the University of California, Berkeley, described these regulations as “layers of permission” for accessing health data.
He recounted his own experience: “When I started this work, it was incredibly challenging to access the necessary data here in the U.S. I actually ended up doing my research in Sweden. That process took a decade, which was still quicker than trying to obtain data here, even with strict data regulations in Europe.”
Obermeyer further emphasized, “The main issue is the multiple layers of approvals required to handle health data.”
During the hearing, Rep. Byron Donald from Florida inquired about the potential implications of integrating artificial intelligence into medical practices on the healthcare workforce.
Obermeyer replied that while it would alter job roles, it would not necessarily lead to job losses as some fear. “History has shown us that automation and technology don’t typically eliminate jobs; they transform them,” he noted. “Doctors will need to engage with these tools and learn to use them effectively. This could enhance the abilities of nurses and community health workers, providing them with access to advanced technology that helps them make better decisions.”
When Donald asked whether the Affordable Care Act’s regulatory framework supports such innovations in healthcare, Obermeyer stated he couldn’t comment on Obamacare specifically, but spoke to regulation in general.
“Currently, there aren’t strong incentives for many health systems to adopt AI technology,” he explained. “The recent access program announced by the Center for Medicare and Medicaid Services is a positive step, as it promotes preventive care enhanced by technology.”
He mentioned that AI could help “reduce costs” and “identify fraud, waste, and abuse in the system.”
The panels present were the Subcommittee on Economic Growth, Energy Policy, and Regulatory Affairs and the Subcommittee on Health Care and Financial Services.
Rep. Brandon Gill from Texas posed a question to Chris Jacobs, founder of Juniper Research Group, regarding the Affordable Care Act. Jacobs reiterated that Obamacare was proposed to lower premiums, citing a $2,500 reduction mentioned by President Obama. He questioned whether that promise had been fulfilled.
Jacobs asserted that premiums for individual health insurance plans under the Affordable Care Act more than doubled within its first four years, primarily due to regulatory mandates. He pointed out that premiums continue to rise significantly, particularly on exchanges compared to employer-sponsored coverage.
Gill followed up by asking if Jacobs believed Obamacare had any meaningful impact on slowing premium growth.
Jacobs replied, “If anything, it had the opposite effect.”
